Kun Ke
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Oncology 5
- Pancreatic and Hepatic Oncology Research 2
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Xiaolong Liu (13 shared papers)Jingfeng Liu (10 shared papers)Yingchao Wang (11 shared papers)Bixing Zhao (10 shared papers)Naishun Liao (7 shared papers)Weimin Chen (1 shared paper)Xiaoyuan Zheng (7 shared papers)Yiping Mou (4 shared papers)
- Journals
- Cancer Management and Research (2 papers)Frontiers in Oncology (2 papers)Frontiers in Immunology (2 papers)Annals of Vascular Surgery (2 papers)Brachytherapy (2 papers)
- Partner nations
- ChinaMacaoSwitzerland
In The Last Decade
Kun Ke
36 papers receiving 689 citations
Peers
Comparison fields: 5 of 49
- Biological Psychiatry 7
- Hepatology 64
- Oncology 86
- Cancer Research 48
- Immunology 33
Countries citing papers authored by Kun Ke
This map shows the geographic impact of Kun Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Ke more than expected).
Fields of papers citing papers by Kun Ke
This network shows the impact of papers produced by Kun Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Ke. The network helps show where Kun Ke may publish in the future.
Co-authors
The 25 scholars most cited alongside Kun Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 67 | |
| 2 | 2014 | 49 | |
| 3 | 2019 | 41 | |
| 4 | 2019 | 40 | |
| 5 | 2019 | 37 | |
| 6 | 2022 | 36 | |
| 7 | 2020 | 35 | |
| 8 | 2019 | 33 | |
| 9 | 2022 | 32 | |
| 10 | 2022 | 30 | |
| 11 | 2023 | 29 | |
| 12 | 2020 | 26 | |
| 13 | 2021 | 25 | |
| 14 | 2024 | 25 | |
| 15 | 2018 | 20 | |
| 16 | 2013 | 16 | |
| 17 | 2018 | 15 | |
| 18 | 2020 | 15 | |
| 19 | 2017 | 14 | |
| 20 | 2019 | 14 |
About Kun Ke
Kun Ke is a scholar working on Hepatology, Oncology, Immunology, Cancer Research and Molecular Biology, having authored 38 papers that have together received 697 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Immune cells in cancer (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Extracellular vesicles in disease (2 papers), Pluripotent Stem Cells Research (1 paper), Case Reports on Hematomas (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Biological Psychiatry (7 citations), Hepatology (64 citations), Oncology (86 citations), Cancer Research (48 citations) and Immunology (33 citations). Kun Ke has collaborated with scholars based in China, Macao and Switzerland. Frequent co-authors include Xiaolong Liu, Jingfeng Liu, Yingchao Wang, Bixing Zhao, Naishun Liao, Weimin Chen, Xiaoyuan Zheng, Yiping Mou, Zhixiong Cai and Fei Wang. Their work appears in journals such as Cancer Management and Research, Frontiers in Oncology, Frontiers in Immunology, Annals of Vascular Surgery and Brachytherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.